InsiderClue
Insiders · Profile

Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C. at Tvardi Therapeutics. Filing since 28 Dec 2018. CIK 0001706426

Company
Date
Role
Action
Shares
Amount
Of holding
TVRD Tvardi Therapeutics, Inc.
28 Feb 2025
SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
163
$775.88
2.2%
TVRD Tvardi Therapeutics, Inc.
5 Apr 2024
SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
2,753
$2.28K
3.0%
TVRD Tvardi Therapeutics, Inc.
29 Feb 2024
SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
3,293
$2.93K
3.5%
TVRD Tvardi Therapeutics, Inc.
23 Jun 2023
Sec'y; Chief Compliance & G.C.
Sold on a plan
2,483
$8.72K
2.7%
TVRD Tvardi Therapeutics, Inc.
4 Apr 2023
Sec'y; Chief Compliance & G.C.
Sold at will
2,481
$12.18K
2.7%
TVRD Tvardi Therapeutics, Inc.
3 Mar 2023
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
6,256
$60.75K
6.3%
TVRD Tvardi Therapeutics, Inc.
8 Feb 2023
SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
7,770
$4.12K
7.6%
TVRD Tvardi Therapeutics, Inc.
21 Dec 2022
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
2,561
$28.86K
2.5%
TVRD Tvardi Therapeutics, Inc.
1 Apr 2022
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
1,642
$19.56K
1.6%
TVRD Tvardi Therapeutics, Inc.
3 Mar 2022
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
1,787
$20.34K
1.7%
TVRD Tvardi Therapeutics, Inc.
25 Feb 2022
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
1,972
$20.29K
1.9%
TVRD Tvardi Therapeutics, Inc.
30 Aug 2021
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
1,759
$24.98K
2.4%
TVRD Tvardi Therapeutics, Inc.
5 Mar 2021
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
3,090
$55.56K
5.7%
TVRD Tvardi Therapeutics, Inc.
25 Feb 2021
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
4,004
$77.40K
8.3%
TVRD Tvardi Therapeutics, Inc.
30 Dec 2020
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
1,946
$29.77K
4.4%
TVRD Tvardi Therapeutics, Inc.
21 Apr 2020
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
2,721
$42.34K
6.6%
TVRD Tvardi Therapeutics, Inc.
4 Dec 2019
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
3,980
$67.86K
19.2%
TVRD Tvardi Therapeutics, Inc.
29 May 2019
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
2,303
$49.24K
15.6%
TVRD Tvardi Therapeutics, Inc.
28 Dec 2018
Sec'y; Chief Compliance & G.C.
Sold, plan not stated
3,100
$38.78K
32.7%
19 decisions on file.